OR2K2 and Alzheimer disease: Employing Western blot analysis, our investigation unveiled a significant reduction in OR2K2 levels, both in early (p < 0.01) and advanced (p < 0.001) Braak stages in AD when compared to healthy controls (Figure 1c).